Access cutting-edge lung cancer - non small cell treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Tucson location
Preparing your pre-screening questions…
Access lung cancer - non small cell specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung cancer - non small cell treatment provided free
Check if you qualify for this lung cancer - non small cell clinical trial in Tucson, AZ
No-Cost Study Care
Local to Tucson
Convenient for AZ residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
There is increased interest and knowledge about the lung cancer tumor microenvironment (TME). Investigators hypothesize that patients with better baseline physiologic health will have better post-operative outcomes and that strenuous exercise will alter the TME and genetic make-up of the tumor, improving the tumor immune response. Investigators aim to identify the peri-operative and clinical outcomes that differ based on pre-operative VO2max, HRV and resting heart rate following resection of early-stage lung cancer. The physiologic states that are individual and measurable with wearable devices include but are not limited to VO2max, heart rate variability (HRV), and average resting heart rate. Investgators hypothesize that a patient's pre-operative physiologic function with higher VO2max, HRV and lower resting heart rate will be associated with improved peri-operative and post-operative outcomes. Second, investigators will compare alterations in TME based on targeted pre-operative exercise (60-80% of their VO2 max for 75min/week x2 weeks) compared to normal activity adults following resection of early-stage lung cancer. Investigators hypothesize that strenuous exercise in the pre-operative period will impact the TME by increasing levels of cytokines.
Sponsor: University of Arizona
Yes, this clinical trial (NCT07216209) has an active research site in Tucson, AZ that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for lung cancer - non small cell treatment options in Tucson, AZ, this clinical trial (NCT07216209) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung cancer - non small cell specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all lung cancer - non small cell clinical trials near you to find additional studies recruiting in your area.
See all lung cancer clinical trials recruiting in Tucson — not just this study.
Browse Lung Cancer Trials in Tucson →